PubMed:24224997 / 3012-3247 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/24224997","sourcedb":"PubMed","sourceid":"24224997","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/24224997","text":"TARGIT concurrent with lumpectomy within a risk-adapted approach should be considered as an option for eligible patients with breast cancer carefully selected as per the TARGIT-A trial protocol, as an alternative to postoperative EBRT.","tracks":[{"project":"PubMed_Structured_Abstracts","denotations":[{"id":"T4","span":{"begin":0,"end":235},"obj":"CONCLUSIONS"}],"attributes":[{"subj":"T4","pred":"source","obj":"PubMed_Structured_Abstracts"}]},{"project":"luoyt2021_800_3","denotations":[{"id":"T2","span":{"begin":126,"end":139},"obj":"DP"}],"attributes":[{"subj":"T2","pred":"source","obj":"luoyt2021_800_3"}]},{"project":"Linmchun_800_3","denotations":[{"id":"T4","span":{"begin":126,"end":139},"obj":"DP"}],"attributes":[{"subj":"T4","pred":"source","obj":"Linmchun_800_3"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"PubMed_Structured_Abstracts","color":"#93eaec","default":true},{"id":"luoyt2021_800_3","color":"#ecd493"},{"id":"Linmchun_800_3","color":"#ba93ec"}]}]}}